Cardiff Oncology
Patents, Design & Utilities

Last updated:

List of all Cardiff Oncology patents 4 in total

Status Patent
Application
Utility: PLK1 INHIBITORS AND PSA LEVELS IN PROSTATE CANCER External link
Filling date: 7 Sep 2025 Issue date: 16 Jun 2022
Application
Utility: ONVANSERTIB FOR INHIBITING NON-ADRENERGIC CONTRACTION OF SMOOTH MUSCLE AND PROSTATE CELL PROLIFERATION External link
Filling date: 7 Sep 2025 Issue date: 12 May 2022
Application
Utility: SELECTION AND TREATMENT OF CANCER WITH COMBINATION THERAPIES External link
Filling date: 7 Sep 2025 Issue date: 28 Apr 2022
Application
Utility: PLK1 TARGET PHOSPHORYLATION STATUS AND TREATMENT OF CANCER WITH PLK1 INHIBITORS External link
Filling date: 7 Sep 2025 Issue date: 22 Jul 2021

Showing 1 to 4 of 4 patents.